CTS-Clinical and Translational Science-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2211904, encodeId=8e762211904ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：精神疾病 经验分享：Stage Start Date Under Consideration 06-20-2024 Revision Received 06-20-2024 Submission Pending 05-22-2024 Waiting for Revision 05-21-2024 Decision Made 05-21-2024 Under Consideration 05-20-2024 Decision Made 05-20-2024 Under Consideration 05-08-2024 With Referees 05-08-2024 Under Consideration 04-10-2024 Submission Pending 04-09-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2da15685569, createdName=ms2000000255534963, createdTime=Thu Jun 27 10:52:22 CST 2024, time=2024-06-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138314, encodeId=73bd2138314ff, content=偏重的研究方向：肿瘤;临床基础研究 经验分享：哪位大神知道这是到哪一步了？ Under Consideration 05-20-2023 Decision Made 05-20-2023 Under Consideration 05-15-2023 Submission Pending 05-15-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Mon May 22 08:28:34 CST 2023, time=2023-05-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=908585, encodeId=720e908585fa, content=谁可以分享一下经验投了一个月半。StageStart Date11-23-2020UnderConsideration 11-16-2020Submission 11-13-2020UnderConsideration 11-13-2020Submission 11-12-2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Wed Dec 16 15:32:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589247, encodeId=688e58924ee3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：临床研究的文章，4月11号投稿，16号凌晨收到邮件要求小修，给了四五条意见，要求一周内返修。16号当天修好，17号就收到接收的邮件，同时给了proof，效率非常高。版面费3000美元。官方数据显示每年收到1500+论文，接受率10%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSknGEgqiaUqyN7w4UF1OWicfhFkicAXMMCNsoYXVO2IsIguq78THQOIXzDLSnnOgluGJKPOYYF77hA/132, createdBy=c8112095577, createdName=小周医生天天向上, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103427, encodeId=d9fc110342ea0, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103428, encodeId=e4b71103428bb, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836292, encodeId=190583629299, content=有没有谁投过这个杂志？我的虽然accepted, 但一点高兴不起来，我都想撤稿了，版面费3000美元，而且还不打折。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Thu Apr 20 13:56:41 CST 2017, time=2017-04-20, status=1, ipAttribution=)]

2024-06-27 ms2000000255534963 来自上海

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：精神疾病
经验分享：Stage Start Date
Under Consideration 06-20-2024
Revision Received 06-20-2024
Submission Pending 05-22-2024
Waiting for Revision 05-21-2024
Decision Made 05-21-2024
Under Consideration 05-20-2024
Decision Made 05-20-2024
Under Consideration 05-08-2024
With Referees 05-08-2024
Under Consideration 04-10-2024
Submission Pending 04-09-2024

56 0

[GetPortalCommentsPageByObjectIdResponse(id=2211904, encodeId=8e762211904ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：精神疾病 经验分享：Stage Start Date Under Consideration 06-20-2024 Revision Received 06-20-2024 Submission Pending 05-22-2024 Waiting for Revision 05-21-2024 Decision Made 05-21-2024 Under Consideration 05-20-2024 Decision Made 05-20-2024 Under Consideration 05-08-2024 With Referees 05-08-2024 Under Consideration 04-10-2024 Submission Pending 04-09-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2da15685569, createdName=ms2000000255534963, createdTime=Thu Jun 27 10:52:22 CST 2024, time=2024-06-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138314, encodeId=73bd2138314ff, content=偏重的研究方向：肿瘤;临床基础研究 经验分享：哪位大神知道这是到哪一步了？ Under Consideration 05-20-2023 Decision Made 05-20-2023 Under Consideration 05-15-2023 Submission Pending 05-15-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Mon May 22 08:28:34 CST 2023, time=2023-05-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=908585, encodeId=720e908585fa, content=谁可以分享一下经验投了一个月半。StageStart Date11-23-2020UnderConsideration 11-16-2020Submission 11-13-2020UnderConsideration 11-13-2020Submission 11-12-2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Wed Dec 16 15:32:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589247, encodeId=688e58924ee3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：临床研究的文章，4月11号投稿，16号凌晨收到邮件要求小修，给了四五条意见，要求一周内返修。16号当天修好，17号就收到接收的邮件，同时给了proof，效率非常高。版面费3000美元。官方数据显示每年收到1500+论文，接受率10%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSknGEgqiaUqyN7w4UF1OWicfhFkicAXMMCNsoYXVO2IsIguq78THQOIXzDLSnnOgluGJKPOYYF77hA/132, createdBy=c8112095577, createdName=小周医生天天向上, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103427, encodeId=d9fc110342ea0, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103428, encodeId=e4b71103428bb, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836292, encodeId=190583629299, content=有没有谁投过这个杂志？我的虽然accepted, 但一点高兴不起来，我都想撤稿了，版面费3000美元，而且还不打折。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Thu Apr 20 13:56:41 CST 2017, time=2017-04-20, status=1, ipAttribution=)]

2023-05-22 lmzzzh 来自河南省

偏重的研究方向：肿瘤;临床基础研究
经验分享：哪位大神知道这是到哪一步了？
Under Consideration 05-20-2023
Decision Made 05-20-2023
Under Consideration 05-15-2023
Submission Pending 05-15-2023

81 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211904, encodeId=8e762211904ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：精神疾病 经验分享：Stage Start Date Under Consideration 06-20-2024 Revision Received 06-20-2024 Submission Pending 05-22-2024 Waiting for Revision 05-21-2024 Decision Made 05-21-2024 Under Consideration 05-20-2024 Decision Made 05-20-2024 Under Consideration 05-08-2024 With Referees 05-08-2024 Under Consideration 04-10-2024 Submission Pending 04-09-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2da15685569, createdName=ms2000000255534963, createdTime=Thu Jun 27 10:52:22 CST 2024, time=2024-06-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138314, encodeId=73bd2138314ff, content=偏重的研究方向：肿瘤;临床基础研究 经验分享：哪位大神知道这是到哪一步了？ Under Consideration 05-20-2023 Decision Made 05-20-2023 Under Consideration 05-15-2023 Submission Pending 05-15-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Mon May 22 08:28:34 CST 2023, time=2023-05-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=908585, encodeId=720e908585fa, content=谁可以分享一下经验投了一个月半。StageStart Date11-23-2020UnderConsideration 11-16-2020Submission 11-13-2020UnderConsideration 11-13-2020Submission 11-12-2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Wed Dec 16 15:32:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589247, encodeId=688e58924ee3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：临床研究的文章，4月11号投稿，16号凌晨收到邮件要求小修，给了四五条意见，要求一周内返修。16号当天修好，17号就收到接收的邮件，同时给了proof，效率非常高。版面费3000美元。官方数据显示每年收到1500+论文，接受率10%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSknGEgqiaUqyN7w4UF1OWicfhFkicAXMMCNsoYXVO2IsIguq78THQOIXzDLSnnOgluGJKPOYYF77hA/132, createdBy=c8112095577, createdName=小周医生天天向上, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103427, encodeId=d9fc110342ea0, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103428, encodeId=e4b71103428bb, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836292, encodeId=190583629299, content=有没有谁投过这个杂志？我的虽然accepted, 但一点高兴不起来，我都想撤稿了，版面费3000美元，而且还不打折。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Thu Apr 20 13:56:41 CST 2017, time=2017-04-20, status=1, ipAttribution=)]

2020-12-16 csqzsm

谁可以分享一下经验投了一个月半。StageStart Date11-23-2020UnderConsideration 11-16-2020Submission 11-13-2020UnderConsideration 11-13-2020Submission 11-12-2020

153 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211904, encodeId=8e762211904ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：精神疾病 经验分享：Stage Start Date Under Consideration 06-20-2024 Revision Received 06-20-2024 Submission Pending 05-22-2024 Waiting for Revision 05-21-2024 Decision Made 05-21-2024 Under Consideration 05-20-2024 Decision Made 05-20-2024 Under Consideration 05-08-2024 With Referees 05-08-2024 Under Consideration 04-10-2024 Submission Pending 04-09-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2da15685569, createdName=ms2000000255534963, createdTime=Thu Jun 27 10:52:22 CST 2024, time=2024-06-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138314, encodeId=73bd2138314ff, content=偏重的研究方向：肿瘤;临床基础研究 经验分享：哪位大神知道这是到哪一步了？ Under Consideration 05-20-2023 Decision Made 05-20-2023 Under Consideration 05-15-2023 Submission Pending 05-15-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Mon May 22 08:28:34 CST 2023, time=2023-05-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=908585, encodeId=720e908585fa, content=谁可以分享一下经验投了一个月半。StageStart Date11-23-2020UnderConsideration 11-16-2020Submission 11-13-2020UnderConsideration 11-13-2020Submission 11-12-2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Wed Dec 16 15:32:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589247, encodeId=688e58924ee3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：临床研究的文章，4月11号投稿，16号凌晨收到邮件要求小修，给了四五条意见，要求一周内返修。16号当天修好，17号就收到接收的邮件，同时给了proof，效率非常高。版面费3000美元。官方数据显示每年收到1500+论文，接受率10%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSknGEgqiaUqyN7w4UF1OWicfhFkicAXMMCNsoYXVO2IsIguq78THQOIXzDLSnnOgluGJKPOYYF77hA/132, createdBy=c8112095577, createdName=小周医生天天向上, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103427, encodeId=d9fc110342ea0, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103428, encodeId=e4b71103428bb, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836292, encodeId=190583629299, content=有没有谁投过这个杂志？我的虽然accepted, 但一点高兴不起来，我都想撤稿了，版面费3000美元，而且还不打折。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Thu Apr 20 13:56:41 CST 2017, time=2017-04-20, status=1, ipAttribution=)]

2020-04-19 小周医生天天向上

审稿速度:1.0 | 投稿命中率:25.0
经验分享：临床研究的文章，4月11号投稿，16号凌晨收到邮件要求小修，给了四五条意见，要求一周内返修。16号当天修好，17号就收到接收的邮件，同时给了proof，效率非常高。版面费3000美元。官方数据显示每年收到1500+论文，接受率10%

195 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211904, encodeId=8e762211904ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：精神疾病 经验分享：Stage Start Date Under Consideration 06-20-2024 Revision Received 06-20-2024 Submission Pending 05-22-2024 Waiting for Revision 05-21-2024 Decision Made 05-21-2024 Under Consideration 05-20-2024 Decision Made 05-20-2024 Under Consideration 05-08-2024 With Referees 05-08-2024 Under Consideration 04-10-2024 Submission Pending 04-09-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2da15685569, createdName=ms2000000255534963, createdTime=Thu Jun 27 10:52:22 CST 2024, time=2024-06-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138314, encodeId=73bd2138314ff, content=偏重的研究方向：肿瘤;临床基础研究 经验分享：哪位大神知道这是到哪一步了？ Under Consideration 05-20-2023 Decision Made 05-20-2023 Under Consideration 05-15-2023 Submission Pending 05-15-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Mon May 22 08:28:34 CST 2023, time=2023-05-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=908585, encodeId=720e908585fa, content=谁可以分享一下经验投了一个月半。StageStart Date11-23-2020UnderConsideration 11-16-2020Submission 11-13-2020UnderConsideration 11-13-2020Submission 11-12-2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Wed Dec 16 15:32:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589247, encodeId=688e58924ee3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：临床研究的文章，4月11号投稿，16号凌晨收到邮件要求小修，给了四五条意见，要求一周内返修。16号当天修好，17号就收到接收的邮件，同时给了proof，效率非常高。版面费3000美元。官方数据显示每年收到1500+论文，接受率10%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSknGEgqiaUqyN7w4UF1OWicfhFkicAXMMCNsoYXVO2IsIguq78THQOIXzDLSnnOgluGJKPOYYF77hA/132, createdBy=c8112095577, createdName=小周医生天天向上, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103427, encodeId=d9fc110342ea0, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103428, encodeId=e4b71103428bb, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836292, encodeId=190583629299, content=有没有谁投过这个杂志？我的虽然accepted, 但一点高兴不起来，我都想撤稿了，版面费3000美元，而且还不打折。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Thu Apr 20 13:56:41 CST 2017, time=2017-04-20, status=1, ipAttribution=)]

2021-12-29 ms6000000264964247

引言三段式指的是什么?

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211904, encodeId=8e762211904ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：精神疾病 经验分享：Stage Start Date Under Consideration 06-20-2024 Revision Received 06-20-2024 Submission Pending 05-22-2024 Waiting for Revision 05-21-2024 Decision Made 05-21-2024 Under Consideration 05-20-2024 Decision Made 05-20-2024 Under Consideration 05-08-2024 With Referees 05-08-2024 Under Consideration 04-10-2024 Submission Pending 04-09-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2da15685569, createdName=ms2000000255534963, createdTime=Thu Jun 27 10:52:22 CST 2024, time=2024-06-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138314, encodeId=73bd2138314ff, content=偏重的研究方向：肿瘤;临床基础研究 经验分享：哪位大神知道这是到哪一步了？ Under Consideration 05-20-2023 Decision Made 05-20-2023 Under Consideration 05-15-2023 Submission Pending 05-15-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Mon May 22 08:28:34 CST 2023, time=2023-05-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=908585, encodeId=720e908585fa, content=谁可以分享一下经验投了一个月半。StageStart Date11-23-2020UnderConsideration 11-16-2020Submission 11-13-2020UnderConsideration 11-13-2020Submission 11-12-2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Wed Dec 16 15:32:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589247, encodeId=688e58924ee3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：临床研究的文章，4月11号投稿，16号凌晨收到邮件要求小修，给了四五条意见，要求一周内返修。16号当天修好，17号就收到接收的邮件，同时给了proof，效率非常高。版面费3000美元。官方数据显示每年收到1500+论文，接受率10%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSknGEgqiaUqyN7w4UF1OWicfhFkicAXMMCNsoYXVO2IsIguq78THQOIXzDLSnnOgluGJKPOYYF77hA/132, createdBy=c8112095577, createdName=小周医生天天向上, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103427, encodeId=d9fc110342ea0, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103428, encodeId=e4b71103428bb, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836292, encodeId=190583629299, content=有没有谁投过这个杂志？我的虽然accepted, 但一点高兴不起来，我都想撤稿了，版面费3000美元，而且还不打折。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Thu Apr 20 13:56:41 CST 2017, time=2017-04-20, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

结果中的重要文献是在结果体现，还是在引言中描述？

86 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211904, encodeId=8e762211904ab, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：精神疾病 经验分享：Stage Start Date Under Consideration 06-20-2024 Revision Received 06-20-2024 Submission Pending 05-22-2024 Waiting for Revision 05-21-2024 Decision Made 05-21-2024 Under Consideration 05-20-2024 Decision Made 05-20-2024 Under Consideration 05-08-2024 With Referees 05-08-2024 Under Consideration 04-10-2024 Submission Pending 04-09-2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2da15685569, createdName=ms2000000255534963, createdTime=Thu Jun 27 10:52:22 CST 2024, time=2024-06-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138314, encodeId=73bd2138314ff, content=偏重的研究方向：肿瘤;临床基础研究 经验分享：哪位大神知道这是到哪一步了？ Under Consideration 05-20-2023 Decision Made 05-20-2023 Under Consideration 05-15-2023 Submission Pending 05-15-2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Mon May 22 08:28:34 CST 2023, time=2023-05-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=908585, encodeId=720e908585fa, content=谁可以分享一下经验投了一个月半。StageStart Date11-23-2020UnderConsideration 11-16-2020Submission 11-13-2020UnderConsideration 11-13-2020Submission 11-12-2020, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJc4dkGdPVf2iaxGwCdJzdzc3c2CmlpZ2K0jXmdZib2fb1A0hFqzG5U3KopQetIMfYParZxeXk6wZbA/132, createdBy=8ab747919, createdName=csqzsm, createdTime=Wed Dec 16 15:32:45 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589247, encodeId=688e58924ee3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：临床研究的文章，4月11号投稿，16号凌晨收到邮件要求小修，给了四五条意见，要求一周内返修。16号当天修好，17号就收到接收的邮件，同时给了proof，效率非常高。版面费3000美元。官方数据显示每年收到1500+论文，接受率10%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSknGEgqiaUqyN7w4UF1OWicfhFkicAXMMCNsoYXVO2IsIguq78THQOIXzDLSnnOgluGJKPOYYF77hA/132, createdBy=c8112095577, createdName=小周医生天天向上, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103427, encodeId=d9fc110342ea0, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103428, encodeId=e4b71103428bb, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836292, encodeId=190583629299, content=有没有谁投过这个杂志？我的虽然accepted, 但一点高兴不起来，我都想撤稿了，版面费3000美元，而且还不打折。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c235413991, createdName=ms2848770090237977, createdTime=Thu Apr 20 13:56:41 CST 2017, time=2017-04-20, status=1, ipAttribution=)]

2017-04-20 ms2848770090237977

有没有谁投过这个杂志？我的虽然accepted, 但一点高兴不起来，我都想撤稿了，版面费3000美元，而且还不打折。

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务